Free Trial
OTCMKTS:ASNB

EKIMAS (ASNB) Stock Price, News & Analysis

About EKIMAS Stock (OTCMKTS:ASNB)

Key Stats

Today's Range
N/A
50-Day Range
$2.73
▼
$5.09
52-Week Range
N/A
Volume
41,849 shs
Average Volume
3,162 shs
Market Capitalization
$29.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.

Receive ASNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASNB Stock News Headlines

EKIMAS CORPORATION COMPLETES THE EXERCISE OF WARRANTS
$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
Updated EKIMAS Corporation Announces Special Cash Distribution
What does ‘WYLL’ mean on TikTok and Snapchat?
EKIMAS Corporation (ASNB)
See More Headlines

ASNB Stock Analysis - Frequently Asked Questions

EKIMAS's stock was trading at $5.00 at the beginning of 2026. Since then, ASNB stock has increased by 1.8% and is now trading at $5.0910.

EKIMAS Co. (OTCMKTS:ASNB) posted its quarterly earnings results on Thursday, October, 16th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.02.

Company Calendar

Today
11/13/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:ASNB
Previous Symbol
AMEX:ASB
CIK
1011060
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$290 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-7,902.31%
Return on Assets
-5,274.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.12
Quick Ratio
0.12

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.03 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
5,799,000
Free Float
5,347,000
Market Cap
$29.52 million
Optionable
Not Optionable
Beta
0.37
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:ASNB) was last updated on 10/29/2026 by MarketBeat.com Staff.
From Our Partners